Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,249-1,260 of 1,909
Drug study icon
SuspendedNCT03513549

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In Raleigh
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Bipolarity, Schizophrenia
Device study icon
CompletedNCT03953417

Accelerated Theta Burst in Treatment-Resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Palo Alto
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Device study icon
CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Prahran
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceFrom 18 Years to 70 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01093937

Varenicline (Champix) for Smoking Cessation/Reduction in people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AddictionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Bipolarity, Addiction
Drug study icon
CompletedNCT01305408

Armodafinil Treatment (150 mg/Day) for depression

This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Device study icon
CompletedNCT00186758

Transcranial Magnetic Stimulation in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Hamilton
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
St. Joseph's Healthcare Hamilton
Condition
Bipolarity, Depression
Other study type icon
Not recruitingISRCTN83333181

A research study in Colombia to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illness

This study is not recruiting in Colombia. It focuses on Bipolarity.

In Colombia
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Schizophrenia, ...OtherFrom 18 Years to 65 Years
Countries
Colombia
Sponsor
Queen Mary University of London
Condition
Bipolarity, Schizophrenia, ...
Drug study icon
Not recruitingISRCTN27649427

Efficacy of mifepristone in the treatment of Depression in bipolarity

This study is looking at care and outcomes for people with Depression in bipolarity or Mental and Behavioural Disorders. Taking part may give some people access to Adjunctive treatment with mifepristone (600 mg/day for 7 days) versus placebo, but direct benefit is not guaranteed.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
The Newcastle, North Tyneside And Northumberland Mental Health NHS Trust (UK)
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.